Uterine Cancer Diagnostic Testing Market: Endometrial Biopsy Remains Sought-After Among End-Users

Growing women geriatric demography coupled with ever increasing healthcare expenditure has impelled uterine cancer diagnostic testing market. The uterine cancer diagnostic testing comprises of endometrial biopsy, pelvic examination, dilation and curettage (D&C), transvaginal ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI). Endometrial biopsy is a precise method to diagnose the uterine cancer. However, patients with abnormal vaginal bleeding prior to the test may need a dilation and curettage (D&C) regardless of the finding of abnormal cells in the course of biopsy. These assimilations are according to the report titled “Global Uterine Cancer Diagnostic Testing Market Insights, Forecast to 2025” which has been recently added to the repository of Market Research Hub (MRH). The research study offers in-depth analysis and insights on the key factors that are influencing the growth of the uterine cancer diagnostic testing market.

Request for Free sample copy of this report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1909624

Endometrial biopsy has gained traction as other tests can merely allude the presence of cancer, whereas a biopsy can make an accurate diagnosis. For the execution of an endometrial biopsy, the doctor eradicates a tiny sample of tissue with a very thin tube. With regards to value at the end of 2026, the uterine cancer diagnostic testing market is projected to be valued at USD 3,756.8 million. Furthermore, Asia-Pacific market is set to witness an upsurge in the uterine cancer diagnostic testing market during the assessment period.

North America is estimated to be the dominant force in the uterine cancer diagnostic testing market which can attributed to the latest report released by National Institutes of Health. In the wake of uncontrolled obese demography and increase in the number of post-menopausal women demography, North America remains the force to reckon with.

Uterine Cancer Diagnostic Testing Market: Report Synopsis

The report furnishes a comprehensive analysis on the uterine cancer diagnostic testing. Besides, the report delves into the drivers, restraints, opportunities, challenges and trends associated with the uterine cancer diagnostic testing market. The uterine cancer diagnostic test has been segmented into ultrasound scanning, biopsy procedures and blood tests. Further, ultrasound scanning has been fragmented into abdominal ultrasound scanning and transvaginal ultrasound scanning. Whereas, biopsy procedures has been segmented into endometrial biopsy, hysteroscopy and dilation and curettage. Blood test embodies a thorough blood count test—CBC and CA125 market blood test.

Browse Full Report with TOC@@ https://www.marketresearchhub.com/report/global-uterine-cancer-diagnostic-testing-market-insights-forecast-to-2025-report.html

On the flip side, the report does not incorporate revenue generated from the imaging procedures such as MRI scans, CT scans, X-rays, PET scans, endoscopy procedures and other screening and treatment methods. Besides, the report assesses the uterine cancer diagnostic testing market with regards to test type and end users and furnishes the forecast on the basis of next-8-year value.

The report also incorporates an exhaustive analysis on the companies’ profiles. Some of the prominent players in the market are Abbott, Siemens, Roche Holdings AG, Danaher and Biomerieux SA.

The market starts with the market definition followed by definitions of different cancer test types. Also, the report analyses the strategic moves, areas of interest, and developments undertaken by major players in the market.

Uterine Cancer Diagnostic Testing Market: Research Methodology

An exhaustive research methodology has been embraced with regards to providing a research approach incorporating of secondary and primary research. The insights in the report is the result of an in-depth secondary research, primary interviews and in-house reviews by panel of experts.

The secondary research incorporates company websites, SEC filings and presentations by investors, industry white paper and statistical database. Besides, the primary research embodies face to face interviews, phonic interviews and e-mail interaction. To provide the readers with authentic report, a panel of expert analyzes the data collected from various sources.

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Medical Equipment market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us         

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

This release was published on openPR.